Phytochemical Name : Bilberry extract

Properties Information
PhytoCAT-ID PhytoCAT-1343
Phytochemical name or plant extracts Bilberry extract
PMID 20132040
Literature evidence In this study, we investigated the antiproliferative effects of bilberry extract in relation to its ability to induce apoptosis and affect microtubule assembly and organization in MCF7 human breast cancer cells.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Extract
Source of phytochemicals or plant Extracts Vaccinium myrtillus
Geographical availability Albania, Alberta, Altay, Amur, Arizona, Austria, Baltic States, Belarus, Belgium, British Columbia, Bulgaria, Buryatiya, Central European Rus, Chita, Colorado, Corse, Czechoslovakia, Denmark, East European Russia, Finland, France, Føroyar, Germany, Great Britain, Greece, Greenland, Hungary, Iceland, Idaho, Ireland, Irkutsk, Italy, Japan, Kazakhstan, Khabarovsk, Krasnoyarsk, Mongolia, Montana, Netherlands, Nevada, New Mexico, North Caucasus, North European Russi, Northwest European R, Norway, Oregon, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Transcaucasus, Turkey, Tuva, Ukraine, Utah, Washington, West Siberia, Xinjiang, Yugoslavia
Plant parts NA
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 0.3-0.4 mg/mL against MCF-7
Potency NA
Cell line/ mice model MCF-7
Additional information  We conclude that bilberry extract as ingested by humans, not just the purified anthocyanins it contains, inhibits proliferation of and induces apoptosis in breast cancer cells at its lowest effective concentrations via a mechanism that does not involve action on microtubules or on mitosis. We further conclude that at somewhat higher concentrations the extract modifies microtubule organization in cells and causes accumulation of cells at mitosis by a direct action on microtubules.
PubChem ID NA
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:30006039-2
Safety NA